• <xmp id="1ykh9"><source id="1ykh9"><mark id="1ykh9"></mark></source></xmp>
      <b id="1ykh9"><small id="1ykh9"></small></b>
    1. <b id="1ykh9"></b>

      1. <button id="1ykh9"></button>
        <video id="1ykh9"></video>
      2. west china medical publishers
        Author
        • Title
        • Author
        • Keyword
        • Abstract
        Advance search
        Advance search

        Search

        find Author "卞策" 16 results
        • Individualized Treatment on Patients with Budd-Chiari Syndrome

          目的 探討布-加綜合征的個體化治療。 方法 我們對首都醫科大學附屬復興醫院及宣武醫院、二炮總醫院及其他醫院2004年2月至2009年5月期間會診收治的20例布-加綜合征患者的臨床資料進行回顧性分析。結果 20例患者中術后24 h死亡1例(5.0%),死于DIC; 19例順利出院。19例患者術后均獲隨訪,隨訪時間(34.7±3.3)個月,其中恢復良好者占73.7%(14/19); 1例(5.3%)行腸-腔-頸轉流術者,術后間斷出現肝性腦病,短期住院治療后可以改善; 術后18個月1例(5.3%)行腸-腔轉流術者因全身臟器衰竭死亡。結論 個體化手術治療方案可明顯提高布-加綜合征患者的生存率。

          Release date:2016-09-08 10:49 Export PDF Favorites Scan
        • Surgical Management of Suprarenal Aortic Occlusion with Takayasu’s Arteritis

          目的 探討大動脈炎所致腎動脈上腹主動脈閉塞的手術治療方法。方法 回顧性分析1例腎動脈上腹主動脈閉塞行腹主動脈-雙股動脈人工血管搭橋手術治療的患者的臨床資料,并進行文獻復習。結果 術后患者頭痛明顯好轉,血壓由術前的220/110 mm Hg(1 mm Hg=0.133 kPa)降至160/100 mm Hg,雙下肢踝肱指數由0.50升至1.19。術后2周復查CTA示人工血管通暢,術后3個月復查彩超示人工血管通暢,血壓在(140~150)/(80~95) mm Hg間波動,雙眼視力1.0左右,已恢復正常生活。結論 大動脈炎所致腎動脈上腹主動脈閉塞常會影響多個重要臟器的供血,病變復雜,手術時機及方法的正確選擇及長期抗炎治療可以提高患者的治療效果。

          Release date:2016-09-08 10:54 Export PDF Favorites Scan
        • 兒童巨大頸內動脈瘤切除并直接重建的手術治療(附1例報道)

          Release date:2016-09-08 10:54 Export PDF Favorites Scan
        • 1例股靜脈至無名靜脈金屬異物的外科治療

            患者,男,39歲。3年前因大面積燒傷在外院治療,2年后經X線拍片見一金屬導絲從右股靜脈直到無名靜脈(圖1),遂切開右股靜脈欲取出導絲,但見部分導絲已與靜脈內膜黏合,無法取出,手術失敗; 后再次經對側股靜脈入徑,用抓捕器從無名靜脈將導絲套住并向下行套至第二腰椎水平處即無法下行,考慮腰二椎體以下導絲已與下腔靜脈黏合,再將抓捕器進入右股靜脈也無法抓捕導絲,手術再次失敗(圖2)。后收治于第二炮兵總醫院,決定采用導管套切分離摘取法,經術前準備后于全麻下行第3次手術。手術沿右股部原切口進入,瘢痕密集,分離困難。逐步顯露出右股總及股深淺靜脈并分別過帶控制,沿右股總靜脈觸及硬條索樣物,向下延及股淺靜脈。切開右股總靜脈,見導絲與股靜脈后壁完全貼合,被光滑內膜覆蓋(圖3)。切開后壁內膜顯露導絲,小心地將其自股淺靜脈抽出,檢查導絲完整,試牽引并不會被拉伸或折斷(圖4)。用6 F椎動脈造影管沿導絲插入,導絲由導管壁上的預開孔處引出并固定,此后小心地沿金屬異物推進導管,至進入約5 cm處即無法前進; 換用10 F SteerEase輸送導管以同法推進(圖5),此過程中不斷轉動并前后移動導管,前進十分困難,操作達40 min后導管進入約30 cm至超過腰二水平,小心將導絲和導管向下同時牽引,將異物完整取出(圖6)。患者術后恢復順利,滿意出院。擬服抗凝藥3~6個月。  討論  靜脈內金屬異物多是外傷或醫源性所致,臨床罕見,治療困難。本例長條金屬異物位于無名靜脈和股靜脈之間。以往手術和介入治療未能成功的原因在于導絲在體內時間過長,已與血管融合一體。本例于第二炮兵總醫院成功治療的關鍵在于將導絲從血管融合體中游離出來。避免盲目暴力拉扯,否則會出現導致患者生命危險的大出血。宜選擇直型且韌性好的導管,便于導管旋轉進入且不會損傷周圍靜脈管壁。術中證實導絲無明顯腐蝕表現,所以沿導絲同軸緩慢向上推進導管穿破下腔靜脈的可能性不大。我們將導絲游離端穿入套管后從預先自制的側壁孔引出,在固定導絲的前提下采用推進管鞘的方法 (圖5)完成手術(應用杠桿原理), 這是我們在手術室而不是在導管室施行治療的根本原因,如有條件在透視下緩慢插入導管會更安全。但是必須指出的是,如果在股部切口發現導絲游離端已經被腐蝕且很易折斷時,我們則會中止該治療方案,因為筆者曾手術取出留置體內的自無名靜脈到肝內留存11年的塑料套管,極易折斷,最終是分為數段后全部取出。若本例導絲隨著置入時間的延長,亦達到此程度,顯然不宜采用上述方法。本例手術成功的關鍵在于術前充分準備、可行的方案及術中精細的操作。在取出異物后,可能的大范圍靜脈內膜損傷,因而防止術后附壁血栓形成和肺栓塞至為重要,因而需予抗凝治療。

          Release date:2016-09-08 11:05 Export PDF Favorites Scan
        • Treatment of Stubborn Ascites with Precondition of Circulation of Mesoatrial Shunt

          目的 探討布加綜合征腸房轉流術后頑固性腹水的治療。方法 對2008年收治的1例經多次治療(包括腸房轉流術)后均于短期內復發的布加綜合征患者進行回顧性分析。結果 臨床表現為重度腹水致呼吸困難,CT靜脈造影檢查示腸房人工血管通暢但血流量低,考慮吻合口狹窄所致。術中探查發現吻合口極度狹窄,用帶外支撐環的補片重建吻合口,療效滿意。結論 復雜或經多次手術或介入治療的布加綜合征患者,要遵循個體化治療原則,強調術前明確診斷及選擇正確治療方案和手術方式。

          Release date:2016-09-08 11:05 Export PDF Favorites Scan
        • 布加綜合征介入治療后支架金屬支斷裂取出1例報道

          Release date: Export PDF Favorites Scan
        • 肝外型門靜脈高壓異位出血1 例報道

          Release date: Export PDF Favorites Scan
        • Diagnosis and Treatment of Prehepatic Portal Hypertension

          Objective To explore the clinical presentation and diagnosis and treatment of prehepatic portal hypertension (PPH) and discuss its surgical strategies. Methods Forty-six cases of PPH treated in the 2nd Artillery General Hospital and Peking Union Medical College Hospital from January 2000 to May 2009 were analyzed retrospectively, including 2 cases of Abernethy abnormality. All patients were evaluated by indirect portal vein angiography, CT angiography and (or) portal duplex system Doppler ultrasonography before treament. Surgical strategies included: 23 cases with meso-caval shunt, 8 cases with splenectomy and spleno-renal vein shunt, 1 case with porta-caval shunt, 2 cases with paraumbilical vein-jugular vein shunt, 3 cases with portal azygous disconnection, 1 cases with splenectomy and portal azygous disconnection, 1 case with sigmoidostomy and closed the fistula of sigmoid six months later, 1 case with resection of part of small intestine due to acute extensive thrombosis of portal vein system, 4 cases with selective superior mesenteric artery and (or) splenic artery thrombolytic infusion therapy, 2 cases remained no-surgical option and underwent conservative treatment. Results Forty-four patients were followed-up from 2 months to 5 years, average of 23.4 months, one patient without surgical treatment was lost. Satisfactory outcomes were obtained in 34 patients with various shunts, which expressed as a release of hypersplenism and gastrointestinal hemorrhage. Two cases were treated with meso-caval shunt because of rehemorrhage in month 13 and 24 and one died in month 8 after disconnection, one died on day 40 after thrombolytic therapy due to putrescence of intestines, one who remained no-surgical option underwent hemorrhage 4 months later, and then went well by conservative treatment. Conclusion The key of treatment of PPH is to reduce the pressure of hepatic portal vein. Surgical managements of shunt and selective superior mesenteric artery and (or) splenic artery thrombolytic infusion therapy are safe and effective, but individual treatment strategy should be performed.

          Release date:2016-08-28 03:48 Export PDF Favorites Scan
        • Effect of Venous Retransfusion of Ascites on Treatment of Complicated Patients with Budd-Chiari Syndrome

          Objective To explore the methods and effect of venous retransfusion of ascites on the treatment of the complicated patients with Budd-Chiari syndrome.Methods Eighteen complicated and (or) recrudescent patients with Budd-Chiari syndrome were treated by venous retransfusion of ascites between March 2006 and July 2009. The changes in abdominal girth, body weight, the urine volume of 24 h, liver function, renal function, and serum electrolyte measurements before and after treatment were compared. Results After retransfusion of 5 000 ml to 7 800 ml (mean 6 940 ml) ascites, the abdominal girth of patients decreased (Plt;0.05), the urine volume of 24 h tended to normal and during which no serious side-effect happened. The levels of serum BUN, CREA, prothrombin time (PT), and activated partial thromboplastin time (APTT) decreased significantly (Plt;0.05), furthermore the levels of total albumen and albumin increased significantly (Plt;0.05). The changes of serum electrolyte measurements were not significant (Pgt;0.05). The follow-up period for all the patients was in the range of 4 to 37 months (mean 19 months). Then 12 patients were treated by the second operation at 3-6 months after discharge. Conclusions The ascites retransfusion provides a safe and effective treatment option for patients with refractory ascites, and yields a higher likelihood of discharge compared with conventional paracentesis. It is useful in improving quality of life and winning the operational chance for such as patients with complicated Budd-Chiari syndrome.

          Release date:2016-09-08 10:54 Export PDF Favorites Scan
        • Surgical Treatment of Carotid Body Tumor while Absence of Opposite Carotid

          目的 探討對側頸動脈已被切除的頸動脈體瘤的手術方法。方法 左頸動脈體瘤患者1例,女,54歲。右側頸動脈31年前因右頸動脈體瘤手術已經切除,本次手術以成對的蚊式鉗逐步直接分離至瘤體與頸內動脈的Gordon-Tayler白線,在保證頸內動脈完整的情況下,完整切除瘤體及包裹其內的頸外動脈。結果 患者術后無聲音嘶啞、嗆咳、頭暈等并發癥,順利出院。結論 充分的術前準備及正確的分離平面是保證手術順利的關鍵。

          Release date:2016-09-08 11:04 Export PDF Favorites Scan
        2 pages Previous 1 2 Next

        Format

        Content

      3. <xmp id="1ykh9"><source id="1ykh9"><mark id="1ykh9"></mark></source></xmp>
          <b id="1ykh9"><small id="1ykh9"></small></b>
        1. <b id="1ykh9"></b>

          1. <button id="1ykh9"></button>
            <video id="1ykh9"></video>
          2. 射丝袜